Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in
Antineoplastic Combined Chemotherapy Protocols
/ therapeutic use
Breast Neoplasms
/ diagnostic imaging
Female
Fluorodeoxyglucose F18
/ metabolism
Follow-Up Studies
Glycolysis
Humans
Lymph Nodes
/ diagnostic imaging
Lymphatic Metastasis
Positron Emission Tomography Computed Tomography
/ methods
Preoperative Care
Prognosis
Radiopharmaceuticals
/ metabolism
Retrospective Studies
Tumor Burden
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
03
11
2018
pubmed:
4
4
2019
medline:
18
12
2019
entrez:
4
4
2019
Statut:
ppublish
Résumé
The usefulness of This study examined 199 breast cancers treated with primary systemic chemotherapy (PSC) followed by operation, and determined the values of maximum standardized uptake value (SUV A pathological complete response (pCR) was achieved in 64 breast cancers. Breast cancers with low MTV at baseline had a significantly higher pCR rate than breast cancers with high MTV (47.9% vs. 23.4%; p = 0.0005). High reduction rates (∆) of SUV Low levels of MTV at baseline and a high reduction of SUV
Sections du résumé
BACKGROUND
BACKGROUND
The usefulness of
METHODS
METHODS
This study examined 199 breast cancers treated with primary systemic chemotherapy (PSC) followed by operation, and determined the values of maximum standardized uptake value (SUV
RESULTS
RESULTS
A pathological complete response (pCR) was achieved in 64 breast cancers. Breast cancers with low MTV at baseline had a significantly higher pCR rate than breast cancers with high MTV (47.9% vs. 23.4%; p = 0.0005). High reduction rates (∆) of SUV
CONCLUSIONS
CONCLUSIONS
Low levels of MTV at baseline and a high reduction of SUV
Identifiants
pubmed: 30941655
doi: 10.1245/s10434-019-07325-8
pii: 10.1245/s10434-019-07325-8
pmc: PMC6545174
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2175-2183Subventions
Organisme : Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan
ID : No. 26461963
Références
Ann Oncol. 2007 May;18(5):874-80
pubmed: 17293601
J Nucl Med. 2007 Jun;48(6):932-45
pubmed: 17504879
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
J Surg Oncol. 2013 Feb;107(2):180-7
pubmed: 22948739
Breast Cancer Res Treat. 2013 Sep;141(2):269-75
pubmed: 24026860
Eur J Surg Oncol. 2013 Dec;39(12):1358-63
pubmed: 24120422
Nucl Med Mol Imaging. 2013 Mar;47(1):36-43
pubmed: 24895506
Anticancer Res. 2014 Aug;34(8):4447-55
pubmed: 25075084
J Nucl Med. 2015 Jan;56(1):31-7
pubmed: 25476537
Breast Cancer Res. 2014;16(6):502
pubmed: 25551703
Breast Cancer. 2015 May;22(3):245-52
pubmed: 25874688
J Nucl Med. 2015 Jun;56(6):824-31
pubmed: 25883123
Radiology. 2015 Nov;277(2):358-71
pubmed: 25915099
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1648-1655
pubmed: 26025244
Clin Cancer Res. 2015 Dec 15;21(24):5460-8
pubmed: 26130460
Cancer Res Treat. 2016 Apr;48(2):508-17
pubmed: 26511818
Eur J Nucl Med Mol Imaging. 2016 May;43(5):983-93
pubmed: 26758726
J Nucl Med. 2016 Feb;57 Suppl 1:34S-9S
pubmed: 26834099
J Nucl Med. 2016 Aug;57(8):1183-8
pubmed: 27033896
Front Med (Lausanne). 2016 May 09;3:19
pubmed: 27243012
Breast. 2016 Dec;30:5-12
pubmed: 27569020
Asia Ocean J Nucl Med Biol. 2016 Winter;4(1):3-11
pubmed: 27904868
Mol Imaging Biol. 2017 Aug;19(4):636-644
pubmed: 27981471
Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1145-1154
pubmed: 28188325
Eur J Radiol. 2017 Jul;92:30-36
pubmed: 28624017
Ann Nucl Med. 2017 Aug;31(7):544-552
pubmed: 28646331
Clin Breast Cancer. 2018 Feb;18(1):45-52
pubmed: 28993056
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):328-339
pubmed: 29101445
Ann Nucl Med. 2018 Jan;32(1):44-53
pubmed: 29134565
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288
pubmed: 29616304
Oncotarget. 2018 Mar 27;9(23):16343-16353
pubmed: 29662649
Breast. 2018 Aug;40:106-115
pubmed: 29758503
Eur J Radiol. 2018 Oct;107:158-165
pubmed: 30292261